Red Light Holland Announces Filament Health Obtains Interim Order for Proposed Arrangement

Core Viewpoint - Red Light Holland Corp. is progressing towards the acquisition of Filament Health Corp., with an interim order from the Supreme Court of British Columbia facilitating the process [1][2]. Group 1: Acquisition Details - The Supreme Court of British Columbia issued an interim order allowing Filament to hold a special meeting on April 24, 2026, to consider the acquisition [1]. - Filament shareholders of record as of March 2, 2026, will be eligible to vote at the meeting [2]. - The Filament Board has unanimously recommended that shareholders vote "FOR" the arrangement, deeming it in their best interests [3]. Group 2: Conditions and Approvals - Completion of the acquisition is subject to customary conditions, including court approval, regulatory approval, and a two-thirds majority vote from Filament shareholders [4]. - The arrangement requires a simple majority of votes cast, excluding certain votes to ensure minority approval [4]. Group 3: Company Profiles - Red Light Holland focuses on the legal psychedelic sector, emphasizing data collection and R&D for naturally occurring drug development, including psilocybin truffle sales [6]. - Filament Health is a clinical-stage company developing natural psychedelic drugs, aiming to make safe, standardized medicines widely available [7].